Diketopiperazine



         


Diketopirerazine (DKP) is a by-product of aspartame metabolism. DKP is formed in liquid aspartame-containing products during prolonged storage. It has been implicated in the occurrence of brain tumors and has also been implicated as a cause of uterine polyps and changes in blood cholesterol by FDA toxicologist Dr. Jacqueline Verret in her testimony before the U.S. Senate.





  View Live Article   This article is from Wikipedia. All text is available under the terms of the GNU Free Documentation License